2023
  1. Saad Ullah Khan, Guncem Ozgun Eren, Nazli Atac, Asim Onal, Mohammad Haroon Qureshi, Francis Korshe Cooper, Toghrul Almammadov, Safacan Kolemen, Mehmet Sahin, Fusun Can, Sedat Nizamoglu, Antibacterial type-II InP/ZnO quantum dots via multimodal reactive oxygen species,Chemical Engineering Journal,Volume 480, 2024,148140,ISSN 1385-8947,https://doi.org/10.1016/j.cej.2023.148140.
  2. Kalafat E, Güney Esken G, Demirci O, Ayaz R, Çelik E, Can F; Collaborators. Neutralizing antibody levels and cellular immune response against Omicron variant in pregnant women vaccinated with mRNA and inactivated SARS-CoV-2 vaccines. Ultrasound Obstet Gynecol. 2023 Nov 27. doi: 10.1002/uog.27542. Epub ahead of print. PMID: 38011582. https://doi.org/10.1002/uog.27542.
  3. Kuloğlu, Z.E., Eren, Z., Haykar, B.B., Vatansever, C., Barlas, T., Kuskucu, M.A., Güney-Esken, G., Can, F., (2023). Omicron Positivity in Air of Hospital Settings Gathered COVID-19 Patients, Vaccinated/Unvaccinated Populations. Aerosol Air Qual. Res. 23, 220388. https://doi.org/10.4209/aaqr.220388
  4. Boral, J.; Pınarlık, F.; Ekinci, G.; Can, F.; Ergönül, Ö. Does Emerging Carbapenem Resistance in Acinetobacter baumannii Increase the Case Fatality Rate? Systematic Review and Meta-Analysis. Infect. Dis. Rep. 2023, 15, 564-575. https://doi.org/10.3390/idr15050055
  5. Kuloğlu ZE, Talay ZG, Albayrak Ö, Ergönül Ö, Can F. B cell subtypes in individuals received mRNA or inactivated vaccine boosters after fully vaccinated with CoronaVac: A longitudinal study. Infect Dis Clin Microbiol. 2023;3:257-61. https://doi.org/10.36519/idcm.2023.246
  6. Erol, Ç.; Kuloğlu, Z.E.; Kayaaslan, B.; Esken, G.; Altunsoy, A.; Barlas, T.; Çınar, G.; Hasanoğlu, İ.; Oruç, E.; İncir, S.; et al. BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac. Viruses 2023, 15, 1534. https://doi.org/10.3390/v15071534
  7. Atac N, Onbasli K, Koc I, Yagci Acar H, Can F. Fimbria targeting superparamagnetic iron oxide nanoparticles enhance the antimicrobial and antibiofilm activity of ciprofloxacin against quinolone-resistant E. coli. Microb Biotechnol. 2023 Nov;16(11):2072-2081. doi: 10.1111/1751-7915.14327. Epub 2023 Aug 21. PMID: 37602720; PMCID: PMC10616650.
  8. Bahar Madran, İlker Kayı, Ayşe Beşer, Önder Ergönül, Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study, Vaccine, Volume 41, Issue 31,2023, Pages 4586-4593, ISSN 0264-410X, https://doi.org/10.1016/j.vaccine.2023.06.022.
  9. Ergönül Ö, Keske Ş, Ksinzik A, Güldan M, Özbek L, Azap A, Şimşek-Yavuz S, Can F, Sakarya S. The challenges in the monitoring of infectious diseases after the earthquake in Türkiye in 2023. Lancet Infect Dis. 2023 Jul 4:S1473-3099(23)00362-6. doi: 10.1016/S1473-3099(23)00362-6. Epub ahead of print. PMID: 37419128.
  10. Huang H, Liu M, Sun M, Duan S, Pan S, Liu P, Cheng Z, Ergonul O, Can F, Wang Z, Pang Z, Liu F. Virus-Protein Corona Replacement Strategy to Improve the Antitumor Efficacy of Intravenously Injected Oncolytic Adenovirus. ACS Nano. 2023 Jun 27. doi: 10.1021/acsnano.3c00847. Epub ahead of print. PMID: 37367941.
  11. Isler B, Vatansever C, Özer B, Çınar G, Aslan AT, Falconer C, Bauer MJ, Forde B, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Saltoğlu N, Azap A, Azap Ö, Akova M, Ergönül Ö, Can F, Paterson DL, Harris PNA. Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints. Infect Dis (Lond). 2023 Sep;55(9):607-613. doi: 10.1080/23744235.2023.2226709. Epub 2023 Jun 30. PMID: 37391868.
  12. Keske Ş, Akyol M, Tanrıöver C, Özlüşen B, Akcan RE, Güler U, Sait B, Kaçmaz B, Gönen M, Ergönül Ö. Effectiveness of tocilizumab in non-intubated cases with COVID-19: a systematic review and meta-analysis. Infection. 2023 May 10:1–10. doi: 10.1007/s15010-023-02047-2. Epub ahead of print. PMID: 37162716; PMCID: PMC10170028.
  13. Shoham S, Batista C, Ben Amor Y, Ergonul O, Hassanain M, Hotez P, Kang G, Kim JH, Lall B, Larson HJ, Naniche D, Sheahan T, Strub-Wourgaft N, Sow SO, Wilder-Smith A, Yadav P, Bottazzi ME; Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force. Vaccines and therapeutics for immunocompromised patients with COVID-19. EClinicalMedicine. 2023 May;59:101965. doi: 10.1016/j.eclinm.2023.101965. Epub 2023 Apr 12. PMID: 37070102; PMCID: PMC10091856.
  14. Paraskevi C. Fragkou, Giulia De Angelis, Giulia Menchinelli, Fusun Can, Federico Garcia, Florence Morfin-Sherpa, Dimitra Dimopoulou, Konstantina Dimopoulou, Silvia Zelli, Adolfo de Salazar, Rieke Reiter, Hannah Janocha, Adriano Grossi, Jimmy Omony, Chrysanthi Skevaki, Update of ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2,2023, https://doi.org/10.1016/j.cmi.2023.04.019.
  15. Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydın S, Özdemir B, Khostelidi SN, Klimko N, Cornely O, Zakhour J, Kanj SS, Seidel D, Hoenigl M, Ergönül Ö. COVID-19-associated mucormycosis: A systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023 Mar 13:S1198-743X(23)00122-2. doi: 10.1016/j.cmi.2023.03.008. Epub ahead of print. PMID: 36921716; PMCID: PMC10008766.
  16. Seymen AA, Gulten E, Ozgur E, Ortaç B, Akdemir I, Cinar G, Saricaoglu EM, Guney-Esken G, Akkus E, Can F, Karahan ZC, Azap A, Tuncay E. Clinical evaluation of DIAGNOVIR SARS-CoV-2 ultra-rapid antigen test performance compared to PCR-based testing. Sci Rep. 2023 Mar 17;13(1):4438. doi: 10.1038/s41598-023-31177-8. PMID: 36932107; PMCID: PMC10021059.
2022
  1. Boral J, Genç Z, Pınarlık F, Ekinci G, Kuskucu MA, İrkören P, Kapmaz M, Tekin S, Çakar N, Şentürk E, Yurdakul F, Dikenelli B, Can F, Ergonul O. The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit. Sci Rep. 2022 Dec 2;12(1):20808. doi: 10.1038/s41598-022-25493-8. PMID: 36460749; PMCID: PMC9716169.
  2. Çakmaklı C, Demiralp S, Ergönül Ö, Yeşiltaş S, Yıldırım MA. Role of institutional, cultural and economic factors in the effectiveness of lockdown measures. Int J Infect Dis. 2022 Mar;116:111-113. doi: 10.1016/j.ijid.2021.12.333. Epub 2021 Dec 23. PMID: 34954312; PMCID: PMC8765763.
  3. Lazarus, J.V., Romero, D., Kopka, C.J. et al. A multinational Delphi consensus to end the COVID-19 public health threat. Nature 611, 332–345 (2022). doi:10.1038/s41586-022-05398-2386
  4. Sahin AT, Yurtseven A, Dadmand S, Ozcan G, Akarlar BA, Kucuk NEO, Senturk A, Ergonul O, Can F, Tuncbag N, Ozlu N. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network. Proteomics Clin Appl. 2022 Oct 11:e2200070. doi: 10.1002/prca.202200070. Epub ahead of print. PMID: 36217943.
  5. Kapmaz M, Uymaz DS, Özcan G, Barlas T, Esken G, Manici M, Keske Ş, Kuşkucu M, Can F, Ergönül Ö. A complicated case of monkeypox and viral shedding characteristics. J Infect. 2022 Oct 20:S0163-4453(22)00618-1. doi: 10.1016/j.jinf.2022.10.020. Epub ahead of print. PMID: 36273642; PMCID: PMC9584764.
  6. Celik E, Ozcan G, Vatansever C, Paerhati E, Kuşkucu MA, Dogan O, Cekic SG, Ergonul O, Gürsoy A, Keskin Ö, Can F. Alterations in Vaginal Microbiota among Pregnant Women with COVID-19. J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28132. Epub ahead of print. PMID: 36068653.
  7. Kayabolen A, Akcan U, Özturan D, Ulbegi-Polat H, Sahin GN, Pinarbasi-Degirmenci N, Bayraktar C, Soyler G, Sarayloo E, Nurtop E, Ozer B, Guney-Esken G, Barlas T, Yildirim IS, Dogan O, Karahuseyinoglu S, Lack NA, Kaya M, Albayrak C, Can F, Solaroglu I, Bagci-Onder T. Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo. Adv Sci (Weinh). 2022 Jul 27:e2201294. doi: 10.1002/advs.202201294. Epub ahead of print. PMID: 35896894.
  8. Keske Ş, Esken GG, Vatansever C, Beşli Y, Kuloğlu ZE, Nergiz Z, Barlas T, Şencanlı Ö, Kuşkucu MA, Palaoğlu E, Can F, Ergönül Ö. Duration of infectious shedding of SARS-CoV-2 omicron variant and its relation with symptoms. Clin Microbiol Infect. 2022 Jul 16:S1198-743X(22)00373-1. doi: 10.1016/j.cmi.2022.07.009. Epub ahead of print. PMID: 35853589; PMCID: PMC9287585.
  9. Vatansever C, Ozer B, Atac N, Guler OU, Kilicoglu BK, Berkkan M, Baskurt D, Sever E, Dogan O, Can F. Efficacy of Amikacin and Meropenem on Colistin-Induced Klebsiella pneumoniae Persisters. Microb Drug Resist. 2022 Jul;28(7):765-772. doi: 10.1089/mdr.2021.0207. Epub 2022 Jun 27. PMID: 35759379.
  10. Isler B, Vatansever C, Özer B, Çınar G, Aslan AT, Stewart A, Simos P, Falconer C, Bauer MJ, Forde B, Harris P, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Saltoğlu N, Azap A, Azap Ö, Akova M, Ergönül Ö, Paterson DL, Can F. Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagn Microbiol Infect Dis. 2022 Sep;104(1):115745. doi: 10.1016/j.diagmicrobio.2022.115745. Epub 2022 Jun 18. PMID: 35843111.
  11. Madran B, Akbulut Z, Akbaba G, Taş E, Güçlüoğlu T, Şencanlı Ö, Bozkurt İ, Keske Ş, Ergönül Ö. COVID-19 Severity among Healthcare Workers: Overweight Male Physicians at Risk. Infect Dis Rep. 2022 Apr 25;14(3):310-314. doi: 10.3390/idr14030036. PMID: 35645215; PMCID: PMC9149914.
  12. Kuloğlu ZE, El R, Guney-Esken G, Tok Y, Talay ZG, Barlas T, Kuskucu MA, Albayrak Ö, Doğan Ö, Yavuz SŞ, Midilli K, Ergönül Ö, Can F. Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study. Allergy. 2022 Apr 19. doi: 10.1111/all.15316. Epub ahead of print. PMID: 35437772.
  13. Barac A, Bartoletti M, Azap O, et al. Inappropriate use of ivermectin during the COVID-19 pandemic: Primum non nocere! [published online ahead of print, 2022 Mar 22]. Clin Microbiol Infect. 2022;S1198-743X(22)00161-6. doi:10.1016/j.cmi.2022.03.022
  14. Demirlenk YM, Gücer LS, Uçku D, et al. A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections [published online ahead of print, 2022 Mar 18]. Eur J Clin Microbiol Infect Dis. 2022;10.1007/s10096-022-04429-0. doi:10.1007/s10096-022-04429-0
  15. Isler B, Özer B, Çınar G, et al. Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting [published online ahead of print, 2022 Mar 17]. Eur J Clin Microbiol Infect Dis. 2022;10.1007/s10096-022-04425-4. doi:10.1007/s10096-022-04425-4
  16. Fragkou PC, De Angelis G, Menchinelli G, et al. ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 [published online ahead of print, 2022 Feb 23]. Clin Microbiol Infect. 2022;S1198-743X(22)00084-2. doi:10.1016/j.cmi.2022.02.011
  17. Bartoletti M, Azap O, Barac A, et al. ESCMID COVID-19 living guidelines: drug treatment and clinical management: author’s reply. Clin Microbiol Infect. 2022;28(4):617-618. doi:10.1016/j.cmi.2021.12.025
  18. Çakmaklı C, Demiralp S, Ergönül Ö, Yeşiltaş S, Yıldırım MA. Role of institutional, cultural and economic factors in the effectiveness of lockdown measures. Int J Infect Dis. 2022;116:111-113. doi:10.1016/j.ijid.2021.12.333
  19. Batista C, Hotez P, Amor YB, et al. The silent and dangerous inequity around access to COVID-19 testing: A call to action. EClinicalMedicine. 2022;43:101230. doi:10.1016/j.eclinm.2021.101230
2021
  1. Ergonul O, Tokca G, Keske Ş, et al. Elimination of healthcare associated Acinetobacter baumannii infection in a highly endemic region [published online ahead of print, 2021 Oct 12]. Int J Infect Dis. 2021;S1201-9712(21)00804-3. doi:10.1016/j.ijid.2021.10.011
  2. Yalçın TY, Topçu DI, Doğan Ö, et al. Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study [published online ahead of print, 2021 Sep 1]. J Med Virol. 2021;10.1002/jmv.27316. doi:  10.1002/jmv.27316
  3. Dogan O, Vatansever C, Atac N, et al. Virulence Determinants of Colistin-Resistant K. pneumoniae High-Risk Clones. Biology (Basel). 2021;10(5):436. Published 2021 May 14. doi: 10.3390/biology10050436
  4. Figueroa JP, Hotez PJ, Batista C, Ben Amor Y, Ergonul O, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow DC, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Bottazzi ME. Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed. PLoS Med. 2021 Sep 13;18(9):e1003772. doi: 10.1371/journal.pmed.1003772. PMID: 34516558; PMCID: PMC8475996.
  5. Fotopoulou C, Planchamp F, Aytulu T, et al. European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery. Int J Gynecol Cancer. 2021;31(9):1199-1206. doi: 10.1136/ijgc-2021-002951
  6. Pınarlık F, Genç Z, Kapmaz M, Tekin S, Ergönül Ö. Risk Groups for SARS-CoV-2 Infection among Healthcare Workers: Community Versus Hospital Transmission. Infect Dis Rep. 2021 Aug 13;13(3):724-729. doi: 10.3390/idr13030067. PMID: 34449648; PMCID: PMC8395820.
  7. Hotez PJ, Batista C, Amor YB, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kaslow DC, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Sow SO, Strub-Wourgaft N, Yadav P, Bottazzi ME. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic. EClinicalMedicine. 2021 Sep;39:101053. doi: 10.1016/j.eclinm.2021.101053. Epub 2021 Aug 3. PMID: 34368661; PMCID: PMC8330385.
  8. Shahhosseini N, Wong G, Babuadze G, et al. Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe. Microorganisms. 2021;9(9):1907. Published 2021 Sep 9. doi: 10.3390/microorganisms9091907
  9. Peker Y, Celik Y, Arbatli S, et al. Effect of High-Risk Obstructive Sleep Apnea on Clinical Outcomes in Adults with Coronavirus Disease 2019: A Multicenter, Prospective, Observational Clinical Trial. Ann Am Thorac Soc. 2021;18(9):1548-1559. doi: 10.1513/AnnalsATS.202011-1409OC
  10. Özlüşen B, Kozan Ş, Akcan RE, Kalender M, Yaprak D, Peltek İB, Keske Ş, Gönen M, Ergönül Ö. Effectiveness of favipiravir in COVID-19: a live systematic review. Eur J Clin Microbiol Infect Dis. 2021 Aug 4:1–9. doi: 10.1007/s10096-021-04307-1. Epub ahead of print. PMID: 34347191; PMCID: PMC8335450.
  11. Aydın M, Azak E, Bilgin H, et al. Changes in antimicrobial resistance and outcomes of health care-associated infections. Eur J Clin Microbiol Infect Dis. 2021;40(8):1737-1742. doi: 10.1007/s10096-020-04140-y
  12. Korten V, Gökengin D, Eren G, et al. Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011-2017. AIDS Res Ther. 2021;18(1):4. Published 2021 Jan 9. doi: 10.1186/s12981-020-00328-6
  13. Sahin S, Sezer H, Cicek E, Yagız Ozogul Y, Yildirim M, Icli TB, Polat Korkmaz O, Durcan E, Sulu C, Somay K, Bekdemir B, Borekci S, Yazici D, Deyneli O, Ergonul O, Tabak F, Dikmen Y, Ozkaya HM, Gonen MS, Damci T, Ilkova H, Yumuk VD. The Role of Obesity in Predicting the Clinical Outcomes of COVID-19. Obes Facts. 2021;14(5):481-489. doi: 10.1159/000517180. Epub 2021 Aug 5. PMID: 34352797; PMCID: PMC8450845.
  14. Celik E, Vatansever C, Ozcan G, et al. Placental deficiency during maternal SARS-COV-2 infection. Placenta. 2021. doi: 10.1016/j.placenta.2021.10.012
  15. Torun H, Bilgin B, Ilgu M, et al. Machine learning detects SARS-COV-2 and variants rapidly on DNA aptamer metasurfaces. 2021. doi: 10.1101/2021.08.07.21261749
  16. Ergönül, Ö., Akyol, M., Tanrıöver, C., Tiemeier, H., Petersen, E., Petrosillo, N., Gönen, M. (2021). National case fatality rates of the COVID-19 pandemic. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 27(1), 118–124. doi: 10.1016/j.cmi.2020.09.024
2020
  1. Vatansever C, Menekse S, Dogan O., Gücer L., Ozer B., Ergonul O., Can F. Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235. Emerg Microbes Infect. 2020;9(1):152–154. Published 2020 Jan 21. DOI:10.1080/22221751.2020.1713025
  2. Doğan Ö, Yeşilkaya A, Menekşe Ş, Güler Ö, Karakoç Ç, Çınar G, Kapmaz M, Aydın M, Keske Ş, Şahin S, Hacıseyitoğlu D, Yalçın D, Tekin S, Ataç N, Albayrak Ö, Aksu ED, Can F, Ergönül Ö. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group. Int J Antimicrob Agents. 2020 Jul;56(1):105992. doi: 10.1016/j.ijantimicag.2020.105992. Epub 2020 Apr 24. PMID: 32335275.
  3. Bilici K , Atac N , Muti A , Baylam I , Dogan O , Sennaroglu A , Can F , Yagci Acar H . Broad spectrum antibacterial photodynamic and photothermal therapy achieved with indocyanine green loaded SPIONs under near infrared irradiation. Biomater Sci. 2020 Aug 21;8(16):4616-4625. doi: 10.1039/d0bm00821d. Epub 2020 Jul 17. PMID: 32676631.
  4. Eren ÖC, Yigit YE, Özel M, Tutucu F, Çınar G, Ergönül Ö. HIV as a Chronic Disease: Are Primary Care Physicians Ready? Infect Dis Clin Microbiol 2020; 2: 78-90. doi: 10.36519/idcm.2020.0011
  5. Kayı İ, Yavaş G, Uçurum BE, Yılmaz P, Gökçek B, Oğuzer ŞE, et al. Predictors of Human Papilloma Virus Vaccination Uptake among Female University Students in Turkey. Infect Dis Clin Microbiol 2020; 3: 138-146. doi: 10.36519/idcm.2020.0030
2019
  1. Ozer B, Vatansever C, Doğan Ö, Keske Ş, Ergönül Ö, Can F. Biofilm Formation of Acinetobacter baumannii Under in vitro and in vivo Colistin Exposure. Infect Dis Clin Microbiol 2019; 1: 26-33. DOI: https://doi.org/10.5152/idcm.2019.19004
  2. Onal S, Uludağ G, Metin MM, Onay A, Önder E. A severe sight-threatening complication of herpes zoster ophthalmicus: Orbital Apex Syndrome. Infect Dis Clin Microbiol 2019; 3: 143-148. doi: 10.36519/idcm.2019.19029
  3. Yerlikaya A, Eryılmaz B, Kahyaoğlu B, Ergönül Ö. Rhombencephalitis with Listeria monocytogenes. Infect Dis Clin Microbiol 2019; 1: 47-54. doi: 10.5152/idcm.2019.19008
  4. Yersiniabactin as a promoter of mortality of infections caused by colistin-resistant Klebsiella pneumoniae ST101, Ozlem Dogan, Nazli Atac, Cansel Vatansever, Ozgur Albayrak, Özgün Ekin Sahin, Bilge Kaan Kiliçoglu, Atalay Demiray, Önder Ergönül, Mehmet Gönen, Fusun Can, 13-16 April 2019, 29th The Congress of EECMID
  5. Turkish prospective study on carbapenem-resistant Klebsiella pneumoniae bacteraemia: preliminary results, Burcu Isler, Gule Aydin, Abdullah Tarik Aslan, Melike Hamiyet Demirkaya, Necla Tulek, Ilker Inanc Balkan, Sirin Menekse Yilmaz, Siran Keske, Cansel Vatansever, Berna Ozer, Ozlem Dogan, Funda Simsek, Gülsen Hazirolan, Serap Yagci, Cigdem Arabaci, Mehmet Gönen, Nese Saltoglu, Özlem Kurt Azap, Alpay Azap, Murat Akova, Fusun Can, Önder Ergönül, 13-16 April 2019, 29th The Congress of EECMID
  6. Antibiotic de-escalation opportunities and predictors of fatality in Gram-negative bloodstream infections in Turkey, Mahir Kapmaz, Siran Keske, SudaTekin, Ozlem Dogan, BilgeEmine Dikenelli, Nazli Atac, Cansel Vatansever, Ozgur Albayrak, Zeliha Akbulut, Bahar Madran, Hanife Ebru Dönmez, Berna Ozer, Ekin Deniz Aksu, Defne Baskurt, Mete Berkkan, Veli Oguzalp Bakir, Mehmet Gönen,Fusun Can, Önder Ergönül, 13-16 April 2019, 29th The Congress of EECMID
  7. An emerging threat: colistin resistance in high-risk clone of Pseudomonas aeruginosa, Cansel Vatansever, Sirin Menekse Yilmaz, Ozlem Dogan,Lal Sude Gücer, Berna Ozer, Önder Ergönül, Mehmet Gönen, Fusun Can, 13-16 April 2019, 29th The Congress of EECMID
  8. Biofilm Formation of Acinetobacter baumannii Under in vitro and in vivo Colistin Exposure, Berna Özer, Cansel Vatansever, Özlem Doğan, Şiran Keske, Önder Ergönül, Füsun Can, Infect Dis Clin Microbiol 2019; 1(1): 26-33, DOI: 10.5152/idcm.2019.19004
  9. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis, Ozgur Albayrak, Merih Oray, Fusun Can, Gunay Uludag Kirimli, Ahmet Gul, Ilknur Tugal-Tutkun and Sumru Onal, Invest Ophthalmol Vis Sci. 2019;60:52–63. Doi: 10.1167/iovs.18-25548
  10. Nurtop E, Bayındır Bilman F, Menekse S, Kurt Azap O, Gönen M, Ergonul O, Can F. Promoters of Colistin Resistance in Acinetobacter baumannii Infections. Microb Drug Resist. 2019 Apr 9. doi: 10.1089/mdr.2018.0396. [Epub ahead of print] PMID:30964377
  11. Ramstedt M, Ribeiro IAC, Bujdakova H, Mergulhão FJM, Jordao L, Thomsen P, Alm M, Burmølle M, Vladkova T, Can F, Reches M, Riool M, Barros A, Reis RL, Meaurio E, Kikhney J, Moter A, Zaat SAJ, Sjollema J. Evaluating Efficacy of Antimicrobial and Antifouling Materials for Urinary Tract Medical Devices: Challenges and Recommendations. Macromol Biosci. 2019 May;19(5):e1800384. doi: 10.1002/mabi.201800384. Epub 2019 Mar 18. Review
  12. Albayrak O, Oray M, Can F, Uludag Kirimli G, Gul A, Tugal-Tutkun I, Onal S. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis. Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):52-63. doi: 10.1167/iovs.18-25548.
2018
  1. Atac N, Kurt-Azap O, Dolapci I, Yesilkaya A, Ergonul O, Gonen M, Can F. The Role of AcrAB-TolC Efflux Pumps on Quinolone Resistance of E. coli ST131. Curr Microbiol. 2018 Dec;75(12):1661-1666. doi: 10.1007/s00284-018-1577-y. Epub 2018 Oct 3. PMID:30283991
  2. Keske Ş, Zabun B, Aksoy K, Can F, Palaoğlu E, Ergönül Ö. Rapid Molecular Detection of Gastrointestinal Pathogens and Its Role in Antimicrobial Stewardship. J Clin Microbiol. 2018 Apr 25;56(5). pii: e00148-18. doi: 10.1128/JCM.00148-18. Print 2018 May.
  3. Can F, Menekse S, Ispir P, Atac N, Albayrak O, Demir T, Karaaslan DC, Karahan SN, Kapmaz M, Kurt Azap O, Timurkaynak F, Simsek Yavuz S, Basaran S, Yoruk F, Azap A, Koculu S, Benzonana N, Lack NA, Gönen M, Ergonul O. Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection. J Antimicrob Chemother. 2018 May 1;73(5):1235-1241. doi: 10.1093/jac/dkx532.
  4. Keske Ş, Ergönül Ö, Tutucu F, Karaaslan D, Palaoğlu E, Can F. The rapid diagnosis of viral respiratory tract infections and its impact on antimicrobial stewardship programs. Eur J Clin Microbiol Infect Dis. 2018 Apr;37(4):779-783. doi: 10.1007/s10096-017-3174-6. Epub 2018 Jan 13.
  5. Aydın M, Ergönül Ö, Azap A, Bilgin H, Aydın G, Çavuş SA, Demiroğlu YZ, Alışkan HE, Memikoğlu O, Menekşe Ş, Kaya Ş, Demir NA, Karaoğlan I, Başaran S, Hatipoğlu Ç, Erdinç Ş, Yılmaz E, Tümtürk A, Tezer Y, Demirkaya H, Çakar ŞE, Keske Ş, Tekin S, Yardımcı C, Karakoç Ç, Ergen P, Azap Ö, Mülazımoğlu L, Ural O, Can F, Akalın H; Turkish Society of Clinical Microbiology and Infectious Diseases, Healthcare-related Infections Study Group, Turkey. Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections. J Hosp Infect. 2018 Mar;98(3):260-263. doi: 10.1016/j.jhin.2017.11.014. Epub 2017 Dec 15.
  6. Ergönül, Ö., Keske, Ş., Çeldir, M. G., Kara, İ. A., Pshenichnaya, N., Abuova, G., Blumberg, L., Gönen, M. (2018). Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers. Emerging Infectious Diseases, 2018: 24(9), 1642–1648. doi: 10.3201/eid2409.171709
2017
  1. Ergönül Ö, Şeref C, Eren Ş, Çelikbaş A, Baykam N, Dokuzoğuz B, Gönen M, Can F. Cytokine response in crimean-congo hemorrhagic fever virus infection. J Med Virol. 2017 Oct;89(10):1707-1713. doi: 10.1002/jmv.24864. Epub 2017 Jul 6.
2016
  1. Onder E, Can Ege Y, Mahmut Alp E, Demirci M, Uysal SP, Ay NZ, Omeroglu A. Who can get the next Nobel Prize in infectious diseases? International Journal of Infectious Diseases 2016:88-91. doi: 10.1016/j.ijid.2016.02.022.
  2. Ergönül Ö, Aydin M, Azap A, Başaran S, Tekin S, Kaya Ş, Gülsün S, Yörük G, Kurşun E, Yeşilkaya A, Şimşek F, Yılmaz E, Bilgin H, Hatipoğlu Ç, Cabadak H, Tezer Y, Togan T, Karaoğlan I, İnan A, Engin A, Alışkan HE, Yavuz SŞ, Erdinç Ş, Mulazimoglu L, Azap Ö, Can F, Akalın H, Timurkaynak F; Turkish Society of Clinical Microbiology and Infectious Diseases, Healthcare-Related Infections Study Group. Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect. 2016 Dec;94(4):381-385. doi: 10.1016/j.jhin.2016.08.012. Epub 2016 Aug 21.
  3. Can F, Kurt-Azap Ö, İspir P, Nurtop E, Seref C, Loçlar İ, Aktaş ON, Orhan YC, Ergonul O. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli. J Glob Antimicrob Resist. 2016 Mar;4:49-52. doi: 10.1016/j.jgar.2015.10.006. Epub 2015 Nov 14.
  4. Can F, Kurt-Azap O, Nurtop E, Ispir P, Seref C, Ergonul O. Molecular epidemiology of bloodstream-associated Escherichia coli ST131 H30-Rx subclone infection in a region with high quinolone resistance. J Med Microbiol. 2016 Apr;65(4):306-310. doi: 10.1099/jmm.0.000224. Epub 2016 Jan 20.
2014
  1. Ince, Y., Yasa, C., Metin, M., Sonmez, M., Meram, E., Benkli, B., Ergonul, O. (2014). Crimean-Congo hemorrhagic fever infections reported by ProMED. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014: 26, 44–46. doi: 10.1016/j.ijid.2014.04.005
  2. Can F, Azap OK, Seref C, Ispir P, Arslan H, Ergonul O. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clin Infect Dis. 2015 Feb 15;60(4):523-7. doi: 10.1093/cid/ciu864. Epub 2014 Nov 6.
2013
  1. Kayıran PG, Can F, Kayıran SM, Ergonul O, Gürakan B. Transmission of methicillin-sensitive Staphylococcus aureus to a preterm infant through breast milk. J Matern Fetal Neonatal Med. 2014 Mar;27(5):527-9. doi: 10.3109/14767058.2013.819332. Epub 2013 Jul 24.